Sonali Patil (PhD)

Sonali Patil (PhD) has a diverse work experience in the field of scientific research and drug discovery. Sonali started their career as a Senior Scientist and Manager at Connexios Life Sciences Pvt. Ltd, where they managed a team responsible for manually curating molecular pathways for Diabetes type II. Sonali also studied ontologies to help create their proprietary knowledge base.

Sonali then worked as a Volunteer at Kellogg School of Management, Northwestern University, followed by a role as a Bio-Informaticist at Mount Sinai Health System. Here, they developed a knowledge base of signaling networks of dendritic cells in response to pathogens and explored different pathway building tools.

Sonali's next role was as a Researcher at Icahn School of Medicine at Mount Sinai, where they conducted doctoral studies. Sonali then joined Five Prime Therapeutics, Inc. as a Scientist, contributing significantly to a collaboration with a global pharmaceutical client to identify novel drugs/targets for alleviating exacerbations in COPD patients in response to bacterial infections.

Currently, Sonali is working at CytomX Therapeutics as a Scientist. Sonali is leading a collaboration with Astellas Pharma to develop novel T cell bispecific therapeutics using CytomX's proprietary Probody platform. Sonali is responsible for project management tasks, including overall project leadership, coordination of efforts across functional groups, and communication with CROs. Sonali also conducts scientific research, leading hybridoma screening efforts and designing in vivo studies for efficacy and safety evaluation.

Sonali's work experience showcases their expertise in scientific research, drug discovery, project management, and bioinformatics.

Sonali Patil (PhD) obtained their Bachelor's degree in Chemistry from Savitribai Phule Pune University in 1995. Sonali then pursued a Master of Science (M.S.) in Biochemistry at the University of Pune from 1995 to 1997. In 2000, Sonali Patil enrolled at the University of Southern California and earned a Master of Science (M.S.) in Computational Molecular Biology, which they completed in 2002. Building on their previous studies, they went on to pursue a Doctor of Philosophy (Ph.D.) in Biomedical Sciences at the Icahn School of Medicine at Mount Sinai from 2008 to 2014.